✦ LIBER ✦

Safety of Infliximab in Inflammatory Bowel Disease Needs to Be Debated

✍ Scribed by de Vries, Hilbert S.; Van Oijen, Martijn G.H.; de Jong, Dirk J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab in children with inflammatory

✍ M. Paganelli; P. Lionetti; G. Lombardi; A. Ravelli; A. Barabino; G. Guariso; C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Safety of infliximab treatment in pediat

✍ Scarbrough, Mark; Calabro, Cheryl; Carpenter, Ellen; Bendorf, Kathy; Friesen, Cr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Safety of Infliximab and Other Biologic

✍ Reddy, Jagadeshwar G.; Loftus, Edward V. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 195 KB

P140 - Adherence to scheduled infliximab

✍ I. Theodoropoulos; A. Smyrnidis; C. Karakoidas; E. Archavlis; K. Papamichael; N. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 58 KB

Safety of biologics in inflammatory bowe

✍ Wojciech Blonski; Gary R. Lichtenstein 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 602 KB

W1272 Predictive Factors of Response to

✍ Bourrier, Anne; Seksik, Philippe; Sokol, Harry; Johanet, Catherine; Nion-Larmuri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB